B Busse
Overview
Explore the profile of B Busse including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
35
Citations
400
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Allahyari P, Silani M, Yaghoubi V, Milovanovic P, Schmidt F, Busse B, et al.
J Mech Behav Biomed Mater
. 2022 Nov;
137:105530.
PMID: 36334581
Bone encompasses a complex arrangement of materials at different length scales, which endows it with a range of mechanical, chemical, and biological capabilities. Changes in the microstructure and characteristics of...
2.
A finite element study on femoral locking compression plate design using genetic optimization method
Rostamian R, Silani M, Ziaei-Rad S, Busse B, Qwamizadeh M, Rabczuk T
J Mech Behav Biomed Mater
. 2022 May;
131:105202.
PMID: 35500494
The locking compression plate (LCP) and screw sets are widely used as internal fixator assemblies to treat long bone fractures. However, the surgeon's critical challenge is choosing the implant set...
3.
von Kroge S, Wolfel E, Buravkova L, Atiakshin D, Markina E, Schinke T, et al.
Eur Cell Mater
. 2021 Oct;
42:220-231.
PMID: 34642917
Space missions provide the opportunity to investigate the influence of gravity on the dynamic remodelling processes in bone. Mice were examined following space flight and subsequent recovery to determine the...
4.
Tonelli F, Cotti S, Leoni L, Besio R, Gioia R, Marchese L, et al.
Matrix Biol
. 2020 Mar;
90:40-60.
PMID: 32173581
Prolyl 3-hydroxylation is a rare collagen type I post translational modification in fibrillar collagens. The primary 3Hyp substrate sites in type I collagen are targeted by an endoplasmic reticulum (ER)...
5.
Schmidt F, Zimmermann E, Campbell G, Sroga G, Puschel K, Amling M, et al.
Bone
. 2017 Jan;
97:243-251.
PMID: 28109917
Aging and many disease conditions, most notably diabetes, are associated with the accumulation of non-enzymatic cross-links in the bone matrix. The non-enzymatic cross-links, also known as advanced glycation end products...
6.
Krause M, Soltau M, Zimmermann E, Hahn M, Kornet J, Hapfelmeier A, et al.
Eur Cell Mater
. 2014 Sep;
28:152-63.
PMID: 25241965
Due to their well-established fracture risk reduction, bisphosphonates are the most frequently used therapeutic agent to treat osteoporosis. Bisphosphonates reduce fracture risk by suppressing bone resorption, but the lower bone...
7.
Simon M, Beil F, Ruther W, Busse B, Koehne T, Steiner M, et al.
Osteoporos Int
. 2014 Apr;
25(7):1891-903.
PMID: 24777741
Unlabelled: Chronic environmental fluoride exposure under calcium stress causes fragility fractures due to osteoporosis and bone quality deterioration, at least in sheep. Proof of skeletal fluorosis, presenting without increased bone...
8.
Carriero A, Zimmermann E, Paluszny A, Tang S, Bale H, Busse B, et al.
J Bone Miner Res
. 2014 Jan;
29(6):1392-1401.
PMID: 24420672
The multiscale hierarchical structure of bone is naturally optimized to resist fractures. In osteogenesis imperfecta, or brittle bone disease, genetic mutations affect the quality and/or quantity of collagen, dramatically increasing...
9.
Carriero A, Doube M, Vogt M, Busse B, Zustin J, Levchuk A, et al.
Bone
. 2013 Dec;
61:116-24.
PMID: 24373921
Osteogenesis imperfecta (brittle bone disease) is caused by mutations in the collagen genes and results in skeletal fragility. Changes in bone porosity at the tissue level indicate changes in bone...
10.
Bernhard A, Milovanovic P, Zimmermann E, Hahn M, Djonic D, Krause M, et al.
Osteoporos Int
. 2013 May;
24(10):2671-80.
PMID: 23632826
Summary: We analyzed morphological characteristics of osteons along with the geometrical indices of individual osteonal mechanical stability in young, healthy aged, untreated osteoporotic, and bisphosphonate-treated osteoporotic women. Our study revealed...